Endometrial Cancer Approval Broadened; Mask Requirements in Cancer Centers; NPR Journalist Passes Away
— Updates, insights, and discussions on cancer-related topics The FDA has broadened the approval for dostarlimab (Jemperli), now allowing its use alongside chemotherapy for treating patients with primary advanced or recurrent endometrial cancer, including those with mismatch repair proficient or microsatellite stable tumors. A recent survey in the journal Menopause highlighted that 37% of women are unaware that postmenopausal bleeding is a critical indicator of endometrial cancer. In another
6 likes
203 views